Identity and percentage holding of significant shareholders
Substantial holdings | Shares held | % |
---|---|---|
Calculus Capital | 6,588,032 | 19.4% |
M&G Investment Mgt | 5,178,143 | 15.3% |
BGF Investment Management Limited | 4,347,826 | 12.8% |
Odey Asset Management | 1,880,266 | 5.5% |
River & Mercantile Asset Management | 1,819,957 | 5.4% |
Directors and related shareholders | ||
Ian Gilham | 266,424 | 0.8% |
David Budd | 145,380 | 0.4% |
Matthew Fowler | 86,957 | 0.3% |
Tom Lindsay | 65,217 | 0.2% |
Chris Yates | 16,304 | - |
Total Directors' holdings | 580,282 | 1.7% |
Total shares in issue | 34,000,506 | 100.00% |
Shareholder information
genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.
Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.
Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 34,000,506.
Number of AIM securities not in public hands is 580,282 or 1,7%, there are no shares subject to lock-ins.
This data was updated on 2nd January 2019.
Latest reports

12 December 2018
Annual Report and Accounts 2018
Investor News
Tuesday January 15, 2019
Genedrive receives second order from US Department of Defense
Thursday November 29, 2018
US giant AbbVie to fund trial of genedrive's hep C test
Thursday November 22, 2018
Genedrive 'well placed' to grow the business after £6mln equity raise